We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLE:NASDAQSuper League Enterprise, Inc. Analysis

Data as of 2026-06-06 - not real-time

$3.33

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Super League Enterprise is trading just above its recent support level, with a 20‑day moving average that sits slightly higher than the current price, suggesting limited upside in the immediate term. Technical indicators show a neutral trend but a bearish MACD crossover and an RSI hovering in the lower‑mid range, while volume has been on a downtrend, highlighting waning short‑term buying pressure. The stock’s volatility is extreme and its beta is negative, indicating an inverse relationship to the broader market and adding to price uncertainty. On the fundamentals side, the company has a solid cash cushion relative to its modest revenue base, and recent quarters have shown modest top‑line growth and an improving gross margin driven by a more disciplined delivery model. However, operating and net margins remain deeply negative, and free cash flow is still in the red, underscoring ongoing profitability challenges. The recent acquisition of a niche advertising business was funded without diluting equity, and management signals confidence that the expanded capabilities will drive EBITDA profitability by fiscal year‑end. Analyst targets imply a multi‑fold upside from current levels, but the market cap remains tiny, and liquidity is thin with decreasing trading volumes.
Given the blend of a strong balance sheet, incremental revenue improvements, and a clear path toward profitability, the stock appears undervalued relative to its asset base, yet the high volatility, negative earnings, and liquidity constraints elevate overall risk. Investors should weigh the upside potential against the near‑term earnings drag and the lack of dividend income before deciding on exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD and decreasing volume
  • Price near recent support
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improving gross margin and revenue growth
  • Strong cash position relative to size
  • Management guidance toward EBITDA profitability

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Undervaluation relative to book value
  • Potential multi‑fold upside per analyst targets
  • Negative beta offering diversification benefit

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin-176.64%
P/E Ratio0.0
ROE-370.65%
ROA-57.97%
P/B Ratio0.2
Op. Cash Flow$-10992000
Free Cash Flow$-11211500
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI40.3
Support$3.05
Resistance$7.07
MA 20$4.23
MA 50$4.01
MA 200$15.65
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Target Price$14.50
Upside/Downside335.44%
GradeUndervalued
TypeBlend

Risk Assessment

Beta-0.67
Volatility154.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.